Advisory Research’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-5,667
| Closed | -$703K | – | 250 |
|
2023
Q4 | $703K | Sell |
5,667
-3,322
| -37% | -$412K | 0.11% | 195 |
|
2023
Q3 | $1.04M | Sell |
8,989
-2,664
| -23% | -$309K | 0.14% | 190 |
|
2023
Q2 | $1.37M | Buy |
+11,653
| New | +$1.37M | 0.18% | 161 |
|
2023
Q1 | – | Sell |
-10,354
| Closed | -$820K | – | 384 |
|
2022
Q4 | $820K | Sell |
10,354
-465
| -4% | -$36.8K | 0.08% | 185 |
|
2022
Q3 | $754K | Sell |
10,819
-5,022
| -32% | -$350K | 0.07% | 187 |
|
2022
Q2 | $1.04M | Sell |
15,841
-2,890
| -15% | -$190K | 0.1% | 154 |
|
2022
Q1 | $1.25M | Buy |
18,731
+12,392
| +195% | +$825K | 0.1% | 165 |
|
2021
Q4 | $443K | Buy |
+6,339
| New | +$443K | 0.03% | 266 |
|